GoodRx (GDRX) Competitors $3.95 +0.09 (+2.33%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$3.95 0.00 (0.00%) As of 10/24/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GDRX vs. AMTM, STNE, WPP, FTDR, DGNX, DLO, WSC, HRI, HNGE, and CARGShould you be buying GoodRx stock or one of its competitors? The main competitors of GoodRx include Amentum (AMTM), StoneCo (STNE), WPP (WPP), Frontdoor (FTDR), Diginex (DGNX), DLocal (DLO), WillScot (WSC), Herc (HRI), Hinge Health (HNGE), and CarGurus (CARG). These companies are all part of the "business services" industry. GoodRx vs. Its Competitors Amentum StoneCo WPP Frontdoor Diginex DLocal WillScot Herc Hinge Health CarGurus Amentum (NYSE:AMTM) and GoodRx (NASDAQ:GDRX) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation. Do analysts prefer AMTM or GDRX? Amentum currently has a consensus price target of $28.55, indicating a potential upside of 26.65%. GoodRx has a consensus price target of $5.80, indicating a potential upside of 46.84%. Given GoodRx's higher possible upside, analysts clearly believe GoodRx is more favorable than Amentum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amentum 2 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33GoodRx 1 Sell rating(s) 6 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is AMTM or GDRX more profitable? GoodRx has a net margin of 4.33% compared to Amentum's net margin of 0.41%. Amentum's return on equity of 10.90% beat GoodRx's return on equity.Company Net Margins Return on Equity Return on Assets Amentum0.41% 10.90% 4.18% GoodRx 4.33%8.86%4.50% Do insiders & institutionals believe in AMTM or GDRX? 39.9% of Amentum shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 18.7% of Amentum shares are owned by insiders. Comparatively, 4.5% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to AMTM or GDRX? In the previous week, Amentum had 2 more articles in the media than GoodRx. MarketBeat recorded 8 mentions for Amentum and 6 mentions for GoodRx. GoodRx's average media sentiment score of 1.02 beat Amentum's score of 0.85 indicating that GoodRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amentum 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, AMTM or GDRX? GoodRx has lower revenue, but higher earnings than Amentum. GoodRx is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmentum$8.39B0.65-$82M$0.3957.79GoodRx$792.32M1.73$16.39M$0.1039.50 SummaryAmentum and GoodRx tied by winning 7 of the 14 factors compared between the two stocks. Get GoodRx News Delivered to You Automatically Sign up to receive the latest news and ratings for GDRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GDRX vs. The Competition Export to ExcelMetricGoodRxMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.37B$8.59B$6.22B$10.81BDividend YieldN/A2.10%5.72%4.81%P/E Ratio39.5082.2131.5430.95Price / Sales1.7342.77595.06133.74Price / Cash12.4221.6737.2561.86Price / Book2.097.8412.056.61Net Income$16.39M$250.93M$3.34B$277.10M7 Day Performance3.13%3.31%1.93%2.57%1 Month Performance0.51%1.90%7.77%3.79%1 Year Performance-36.39%18.01%56.40%33.01% GoodRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GDRXGoodRx3.6357 of 5 stars$3.95+2.3%$5.80+46.8%-36.6%$1.37B$792.32M39.50950Analyst DowngradeAMTMAmentum4.0004 of 5 stars$23.69+1.3%$28.55+20.5%-24.8%$5.69B$8.39B11.4153,000News CoverageAnalyst ForecastSTNEStoneCo3.8883 of 5 stars$17.03-1.2%$16.56-2.7%+68.1%$4.93B$2.46B-24.3316,793Positive NewsAnalyst ForecastWPPWPP1.8775 of 5 stars$22.67+0.6%N/A-55.1%$4.86B$18.84B3.80108,044Trending NewsAnalyst ForecastFTDRFrontdoor3.7264 of 5 stars$65.20+1.0%$59.75-8.4%+37.1%$4.70B$1.84B16.462,120News CoveragePositive NewsAnalyst UpgradeDGNXDiginexN/A$25.70+3.1%N/AN/A$4.59BN/A0.0021Analyst ForecastShort Interest ↓Gap UpDLODLocal2.9863 of 5 stars$14.20+4.3%$14.00-1.4%+72.9%$4.25B$745.97M29.581,095News CoverageAnalyst ForecastWSCWillScot4.7085 of 5 stars$21.75+0.7%$32.13+47.7%-40.2%$3.93B$2.40B15.654,500News CoverageUpcoming EarningsAnalyst ForecastHRIHerc2.9648 of 5 stars$120.51+2.3%$149.20+23.8%-36.7%$3.91B$3.57B140.137,600News CoverageUpcoming EarningsAnalyst DowngradeHNGEHinge HealthN/A$50.39+1.2%$57.47+14.0%N/A$3.91BN/A0.001,514News CoveragePositive NewsAnalyst ForecastCARGCarGurus3.7977 of 5 stars$33.99+1.5%$38.79+14.1%+14.4%$3.33B$894.38M20.551,282Analyst Forecast Related Companies and Tools Related Companies Amentum Competitors StoneCo Competitors WPP Competitors Frontdoor Competitors Diginex Competitors DLocal Competitors WillScot Competitors Herc Competitors Hinge Health Competitors CarGurus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GDRX) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredUrgent Buy Alert: My Top Three Quantum Computing StocksQuantum computing is the hottest tech trend of the year... With some of these stocks jumping 700%, 2,800% a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoodRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GDRX Stock Alerts